• Aucun résultat trouvé

Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail

N/A
N/A
Protected

Academic year: 2022

Partager "Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail"

Copied!
2
0
0

Texte intégral

(1)

Article

Reference

Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail

LENOIR, Camille, et al.

Abstract

Cytochromes P450 (CYP) are subject to important interindividual variability in their activity due to genetic and environmental factors and some diseases. Limited human data support the idea that inflammation down-regulates CYP activities. Our study aimed to evaluate the impact of orthopedic surgery (acute inflammation model) on the activity of six human CYP. This prospective observational study was conducted in thirty patients who underwent elective hip surgery at the Geneva University Hospitals in Switzerland. The Geneva phenotyping cocktail containing caffeine, bupropion, flurbiprofen, omeprazole, dextromethorphan and midazolam as probe drugs respectively assessing CYP1A2, 2B6, 2C9, 2C19, 2D6 and 3A activities was administered orally before surgery, day 1 (D1) and 3 (D3) post-surgery and at discharge.

Capillary blood samples were collected 2h after cocktail intake to assess metabolic ratios (MR). Serum inflammatory markers (CRP, IL-6, IL-1β, TNF-α, IFN-γ) were also measured in blood. CYP1A2 MR decreased by 53% (p

LENOIR, Camille, et al . Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail. Clinical Pharmacology and Therapeutics , 2020

PMID : 33341941 DOI : 10.1002/cpt.2146

Available at:

http://archive-ouverte.unige.ch/unige:149068

Disclaimer: layout of this document may differ from the published version.

1 / 1

(2)

Table S3: Variant alleles frequencies (%).

Isoforms and variant allele Percentage of study population (n)

Predicted phenotype

CYP2B6

*1/*1

*1/*5

83.3 (25) 16.7 (5)

NM NM CYP2C9

*1/*1

*1/*2

*1/*3

*2/*2

56.7 (17) 23.3 (7) 6.7 (2) 10 (3)

NM IM IM PM CYP2C19

*1/*1

*1/*2

*1/*4

*1/*17

*2/*17

*17/*17

50 (15) 13.3 (4) 3.3 (1) 20 (6) 6.7 (2) 3.3 (1)

NM IM IM RM IM UM CYP2D6

*1/*1

*1/*2

*1/*4

*1/*10

*1/*41

*2/*2

*2/*4

*2/*41

*4/*4

*4/*12

*6/*12

*10/*41

13.3 (4) 13.3 (4) 13.3 (4) 6.7 (2) 3.3 (1) 3.3 (1) 16.7 (5) 10 (3) 3.3 (1) 3.3 (1) 3.3 (1) 3.3 (1)

NM (AS = 2) NM (AS = 2) IM (AS = 1) NM (AS = 1.25) NM (AS = 1.25) NM (AS = 2) IM (AS = 1) NM (AS = 1.5) PM (AS = 0) PM (AS = 0) PM (AS = 0) IM (AS = 0.75) AS = activity score, IM = intermediate metabolizer, NM = normal metabolizer, PM = poor metabolizer, RM = rapid metabolizer, UM = ultra-rapid metabolizer.

Références

Documents relatifs

Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.. Basic & Clinical Pharmacology

“The Council of State is convinced that this new body will play a major role in facilitating exchange across different urban fields in Geneva International and

As part of a study evaluating potential drug–drug interactions between probe drugs of the Geneva cocktail, the present paper focuses on the impact of cytochromes (CYP) probe drugs

The purpose of this study was to evaluate the usefulness and effectiveness of DBS sampling for simultaneous assessment of the activities of six CYP isoforms and P-gp using a

Le pinot noir comme on l'aime avec ses notes de fruits noirs et des tanins fondus dans cette cuvée très souple.. Volaille, poêlée légumes d'hiver, sauce champignon,

The Geneva cocktail is composed of a specific probe for six different cytochrome P450 enzymes and one for P-glycoprotein and was used in the context of a research aiming at

This study was a prospective open label observational study investi- gating the impact of elective hip surgery on the activities of 6 major CYPs, namely CYP1A2, CYP2B6,

The Geneva phenotyping cocktail containing caffeine, bupropion, flurbiprofen, omeprazole, dextromethorphan and midazolam as probe drugs respectively assessing CYP1A2, 2B6, 2C9,